Interventional, Randomised, Double-blind, Placebo- and Positive Controlled, Single-dose, Cross-over Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men
Phase of Trial: Phase I
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Idalopirdine (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Adverse reactions
- Sponsors Lundbeck A/S
- 02 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2015 New trial record
- 06 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.